Of note, divergent from other immune response-regulating genes, the expression of CCL2 was rapidly reduced by treatments in CAFs but not in BCC-associated fibroblasts that necessitated prolonged treatment to restore physiological level of this chemokine. Here, CCL2 is linked to skin basal cell carcinoma.